← Back to Analyst Consensus 
HSTM Buy
HEALTHSTREAM INC
Current Price —
Implied Upside —
Analysts 11
30-Day Momentum
▲ 1 upgrades / ▼ 0 downgrades / 0 reiterations from 1 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 13, 2026 | Freedom Capital Markets | initiate | — → Hold | — | 43% |
| Jul 21, 2026 | Canaccord Genuity | maintain | Hold → Hold | — | 48% |
| May 6, 2026 | Canaccord Genuity | maintain | Hold → Hold | — | 48% |
| Dec 17, 2025 | Canaccord Genuity | maintain | Hold → Hold | $28 | 48% |
| Aug 7, 2025 | Canaccord Genuity | maintain | Hold → Hold | $28 | 48% |
| May 15, 2025 | Canaccord Genuity | maintain | Hold → Hold | $29 | 48% |
| Feb 26, 2025 | Canaccord Genuity | maintain | Hold → Hold | $30 | 48% |
| Feb 6, 2025 | JMP Securities | reiterate | Market Perform → Market Perform | $0 | 53% |
| Oct 23, 2024 | Barclays | maintain | Overweight → Overweight | $34 | 53% |
| Oct 23, 2024 | Canaccord Genuity | maintain | Hold → Hold | $29 | 48% |
| Jul 24, 2024 | Canaccord Genuity | maintain | Hold → Hold | $28 | 48% |
| Dec 6, 2023 | JMP Securities | initiate | — → Market Perform | $0 | 53% |
| Feb 22, 2023 | Canaccord Genuity | maintain | — → Hold | $26 | 48% |
| Apr 28, 2021 | Canaccord Genuity | maintain | — → Hold | $24 | 48% |
| Oct 28, 2020 | Canaccord Genuity | maintain | — → Hold | $20 | 48% |
| Dec 20, 2019 | Raymond James | initiate | — → Market Perform | $0 | 54% |
| Jul 11, 2018 | Barrington Research | downgrade | Outperform → Market Perform | $0 | 56% |
| Jun 14, 2018 | Baird | downgrade | Outperform → Neutral | $0 | 55% |
| Oct 25, 2017 | Baird | maintain | — → Outperform | $28 | 55% |
| Oct 25, 2017 | Needham | downgrade | Buy → Hold | $0 | 50% |
| Jul 26, 2017 | First Analysis | upgrade | Underweight → Equal-Weight | $0 | — |
| Jan 23, 2017 | First Analysis | downgrade | Equal-Weight → Underweight | $18 | — |
| Dec 2, 2016 | Baird | upgrade | Neutral → Outperform | $0 | 55% |
| Nov 4, 2016 | Craig-Hallum | downgrade | Buy → Hold | $0 | 54% |
| Nov 4, 2016 | Canaccord Genuity | downgrade | Buy → Hold | $0 | 48% |
| Jul 27, 2016 | First Analysis | downgrade | Overweight → Equal-Weight | $0 | — |
| Jun 29, 2016 | Barrington Research | initiate | — → Outperform | $30 | 56% |
| Mar 29, 2016 | FBR Capital | initiate | — → Outperform | $27 | — |
| Feb 17, 2016 | Needham | upgrade | Hold → Buy | $0 | 50% |
| Aug 3, 2015 | Raymond James | initiate | — → Market Perform | $0 | 54% |
| Jul 22, 2015 | Needham | downgrade | Buy → Hold | $0 | 50% |
| Jul 16, 2015 | Canaccord Genuity | initiate | — → Buy | $37 | 48% |
| May 20, 2015 | Needham | initiate | — → Buy | $0 | 50% |
| Mar 19, 2015 | Baird | initiate | — → Neutral | $27 | 55% |
| Aug 1, 2014 | Northland Capital Markets | upgrade | Market Perform → Outperform | $0 | 50% |
| Jun 17, 2014 | Stifel | initiate | — → Hold | $0 | 53% |
| Apr 2, 2014 | Northland Capital Markets | downgrade | Outperform → Market Perform | $30 | 50% |
| Apr 1, 2014 | Noble Capital Markets | upgrade | Hold → Buy | $34 | 63% |
| Feb 20, 2014 | First Analysis | upgrade | Equal-Weight → Underweight | $36 | — |
| Sep 25, 2013 | Northland Capital Markets | initiate | — → Outperform | $43 | 50% |
| May 28, 2013 | Avondale Partners | upgrade | Market Perform → Market Outperform | $31 | — |
Price Target Trend
Mar 31, 2026 Oct 26, 2026
EPS Estimates
+1q —
0y —
0q —
+1y —
Cross-Platform Signals
No cross-platform signals in the last 90 days